Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
glp 1 agonist mechanism of action of GLP-1 Receptor Agonists Dr. Blum and our tirzepatide Type:Paperback
Dr. Blum and our patient @wesleyk2 are featured in a Men's Health exclusive for Apple News all about microdosing GLP-1s. Check out the full story at the link in our bio! Interested
In 2024 semaglutide (Wegovy) became the first weight loss drug to also be approved for the reduction of risk of serious cardiovascular events in patients with cardiovascular (CV) disease and obesity and overweight
tirzepatide
Type:Paperback
In patients in whom the major therapeutic goal is the compelling need to minimize the therapeutic risk pf hypoglycaemia, DPP-4 inhibitors are recommended as second line therapy after metformin failure at the same level as second line treatment options with GLP-1 receptor agonists, SGLT-2 inhibitors, or TZDs
